| Authors: |
Mazur C; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA., Powers B; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA., Zasadny K; Invicro, LLC, Boston, Massachusetts, USA., Sullivan JM; Invicro, LLC, Boston, Massachusetts, USA.; Biogen, Cambridge, Masschusetts, USA., Dimant H; Invicro, LLC, Boston, Massachusetts, USA., Kamme F; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA., Hesterman J; Invicro, LLC, Boston, Massachusetts, USA., Matson J; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA., Oestergaard M; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA., Seaman M; Invicro, LLC, Boston, Massachusetts, USA., Holt RW; Invicro, LLC, Boston, Massachusetts, USA., Qutaish M; Invicro, LLC, Boston, Massachusetts, USA., Polyak I; Invicro, LLC, Boston, Massachusetts, USA., Coelho R; Invicro, LLC, Boston, Massachusetts, USA., Gottumukkala V; Invicro, LLC, Boston, Massachusetts, USA., Gaut CM; Invicro, LLC, Boston, Massachusetts, USA., Berridge M; 3D Imaging, Little Rock, Arkansas, USA., Albargothy NJ; University of Southampton, Hampshire, United Kingdom., Kelly L; University of Southampton, Hampshire, United Kingdom., Carare RO; University of Southampton, Hampshire, United Kingdom., Hoppin J; Invicro, LLC, Boston, Massachusetts, USA., Kordasiewicz H; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA., Swayze EE; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA., Verma A; Biogen, Cambridge, Masschusetts, USA. |
